NCT03446300

Brief Summary

High myopia retinopathy has become the first cause of irreversible blindness and severe visual impairment in Chinese adults, in order to avoid the blind and visual impairment caused by high myopia retinopathy, it is very necessary to research the mechanism of early visual impairment to prevent and control damages. Our recent research found that the decreasing of macular retina vascular density and subfoveal choroidal thickness, the increasing of Beta Zone area in optic atrophy and the rising of glycosylated hemoglobin in high myopia patients were significantly related to visual impairment, which suggested that the source of visual impairment was the abnormal structure changes surrounding optic and fovea, but so far there is no related study. We will conduct a 5 years prospective cohort study in the population of 2420 high myopia and controls which have established in college student population, working population and aged more than 50 years old population, using the latest OCT-A and SS-OCT to measure macular retina vascular density, subfoveal choroidal thickness, Beta Zone area in optic atrophy, combined with the semiparametric mixed effects model, we will analysis the prediction index between fundus structure parameters, blood biochemical index and individual characteristics prediction to explore the public health management mode of early prevention and treatment during high myopia population.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

February 10, 2018

Completed
16 days until next milestone

First Posted

Study publicly available on registry

February 26, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

February 26, 2018

Status Verified

February 1, 2018

Enrollment Period

4 years

First QC Date

February 10, 2018

Last Update Submit

February 20, 2018

Conditions

Keywords

High Myopia, fundus structure, early visual impairment

Outcome Measures

Primary Outcomes (4)

  • Retina Vessel Density (RVD)

    RVD is calculated both the macular and peripapillary area.

    December 31, 2016

  • tilted optic disc

    A tilted optic disc was defined as the tilt ratios ≤0.80.

    December 31, 2016

  • β-zone PPA

    The β-zone PPA area (an inner crescent of chorioretinal atrophy with good visibility of the large choroidal vessels and the sclera) was determined as the total number of pixels using the ImageJ software in a circumferential pattern.

    December 31, 2018

  • glycosylated hemoglobin

    This test measures the average blood sugar control for the previous three months or so.

    December 31, 2020

Study Arms (3)

college student population

working population

aged more than 50 years old population

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

college student population; working population; aged more than 50 years old population.

You may qualify if:

  • ≥18 years old; spherical equivalent refraction ≤-6.00D;

You may not qualify if:

  • a history of ocular or systemic diseases including congenital cataract and glaucoma; previous intraocular or refractive surgery;other evidence of retinal pathology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Eye Disease Prevention & Treatment Center

Shanghai, Shanghai Municipality, 200040, China

RECRUITING

Related Publications (1)

  • Li M, Xu H, Ye L, Zhou S, Xie J, Liu C, Zhu J, He J, Fan Y, Xu X. Association of macular outward scleral height with axial length, macular choroidal thickness and morphologic characteristics of the optic disc in Chinese adults. Eye (Lond). 2024 Apr;38(5):923-929. doi: 10.1038/s41433-023-02804-5. Epub 2023 Oct 28.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood

MeSH Terms

Conditions

Vision Disorders

Condition Hierarchy (Ancestors)

Sensation DisordersNeurologic ManifestationsNervous System DiseasesEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jianfeng Zhu, PhD, MD

    Shanghai Eye Disease Prevention & Treatment Center

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2018

First Posted

February 26, 2018

Study Start

January 1, 2016

Primary Completion

December 31, 2019

Study Completion

December 31, 2020

Last Updated

February 26, 2018

Record last verified: 2018-02

Locations